Kacper Lechowicz

1.1k citations
14 papers · 677 · 1 hit paper · h-index 10

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
  • Neurology top 10%
    • Long-Term Effects of COVID-19

Papers in

Kacper Lechowicz

13 papers receiving 662 citations

Kacper Lechowicz's Hit Papers

An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment 2021 · 180 citations
1800+1+3Years since publication50100150

Peers

Kacper Lechowicz
Comparison fields: 5 of 108
  • Infectious Diseases 328
  • Neurology 166
  • Critical Care and Intensive Care Medicine 56
  • Developmental Neuroscience 17
  • Applied Microbiology and Biotechnology 8
Replace Sylwester Drożdżal with:
Sylwester Drożdżal Poland
Siu Yan Amy Yeung United States
Farzaneh Dastan Iran
Manoj J. Mammen United States
José Ferreres Spain
Taher Entezari‐Maleki Iran
Engi Algharably Germany
Xin Rao China
F. FERNÁNDEZ Spain
Jason J. Heavner United States
Kacper Lechowicz relative to Sylwester Drożdżal Poland Sylwester Drożdżal's profile →
Citations per field
00.5×1.5×
Sylwester Drożdżal · 1×
Citations per year

Countries citing papers authored by Kacper Lechowicz

Since Specialization
Citations

This map shows the geographic impact of Kacper Lechowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kacper Lechowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kacper Lechowicz more than expected).

Fields of papers citing papers by Kacper Lechowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kacper Lechowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kacper Lechowicz. The network helps show where Kacper Lechowicz may publish in the future.

Co-authors

The 25 scholars most cited alongside Kacper Lechowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kacper Lechowicz Line = papers co-authored together Kacper Lechowicz links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Hit paper breakdown →
2021180
2 2020131
3 2020126
4 202170
5 202047
6 202128
7 201827
8 202023
9 202115
10 202013
11 20197
12 20225
13 20225
14 20230

About Kacper Lechowicz

Kacper Lechowicz is a scholar working on Infectious Diseases, Neurology, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Behavioral Neuroscience, having authored 14 papers that have together received 677 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Intensive Care Unit Cognitive Disorders (4 papers), Stress Responses and Cortisol (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Airway Management and Intubation Techniques (1 paper) and Healthcare professionals’ stress and burnout (1 paper). The work is most often cited by research in Infectious Diseases (328 citations), Neurology (166 citations), Critical Care and Intensive Care Medicine (56 citations), Developmental Neuroscience (17 citations) and Applied Microbiology and Biotechnology (8 citations). Kacper Lechowicz has collaborated with scholars based in Poland, Canada and Iran. Frequent co-authors include Katarzyna Kotfis, Sylwester Drożdżal, Jakub Rosik, Filip Machaj, Bartosz Szostak, Saeid Ghavami, Marek Łoś, Iwona Rotter, Jarosław Przybyciński and Shahrokh Lorzadeh. Their work appears in journals such as Pharmaceuticals, Clinical Interventions in Aging, Drug Resistance Updates, Biomedicine & Pharmacotherapy and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact